PCR – Microbio

Microbio is pleased to share this profile published in The Yield, Spoke Corporate’s Investor and Industry News. Author Simon Shepherdson has perfectly captured Microbio’s exciting history and big plans for the future. https://spokecorporate.com/diagnostic-technology-set-to-change-the-world/

Microbio is pleased to share the Case Study published by Life Sciences Queensland detailing the recent Federal Government Accelerating Commercialisation Grant and commercialisation progress of its pathogen detection products. Read more at: https://www.lsq.com.au/case-study/microbio-new-diagnostic-tests-to-improve-the-identification-of-pathogens/

Microbio Pty Ltd, an Australian-owned biotech company has been awarded a Federal Government Accelerating Commercialisation Grant to commercialise Microbio’s InfectID-Blood Stream Infection (BSI) diagnostic assay. Read more in the full media release.

201123_Microbio_Release_CA_Grant_Success Download

Register your interest

InfectID is evolving rapidly. Fill in the form to keep up with product developments, including the release of Microbio's COVID-19 replicating virus assay.

I am a:
- Pathologist
- Clinician
- Researcher
- Investor
- Product user
- Other
Name
Email
Title
Employer or organisation
Product users: request supporting documents here
- Select All
- Instructions for Use (InfectID-COVID-19) - RotorgeneQ
- Instructions for Use (InfectID-COVID-19) - BMS Mic
Area of interest
Comments
This field is for validation purposes and should be left unchanged.